MARK2 and endometriosis: The key target AKT1, also known as protein kinase B, belongs to the family of serine/threonine kinases that regulate processes such as metabolism, proliferation, growth, and angiogenesis.[24] Studies have shown that inhibiting the activity of AKT1 can effectively improve the pain symptoms of endometriosis and the inflammatory response to relieve the pain symptoms of PD.